Skip to content
All Podcasts – Lifestyle
Author:
ICODA
ICODA CBDO Artem Voinov Attend Blockchain Rio 2026 as Latin America Strengthens Its Position in Global Web3 Growth
July 31, 2026
UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103
July 15, 2026
Crypto Marketing Agency ICODA Releases HackGPT: A Book to Winning AI Search Citations
July 8, 2026
ICODA’s Artem Voinov Launches Consulting Practice for Web3 Founders Seeking the Best Crypto Marketing Specialist
June 15, 2026
UroGen Announces Agreement Resolving Patent Litigation Relating to JELMYTO® (mitomycin) for pyelocalyceal solution
June 2, 2026
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
May 22, 2026
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
May 21, 2026
ICODA Becomes an Official Claude Partner
May 7, 2026
UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights
May 7, 2026